ClinicalTrials.gov
public full text
Public Domain
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation#1171474
- Progesterone Action on Endometrium of PCOS#847600
- Serum phospholipids and sphingolipids are linked to early-stage osteoarthritis by lipidomic profiling#653036
- Effect of Pioglitazone on Inflammation in Cystic Fibrosis#1086275
- Data Management and Sharing Plan for: Metformin to Attenuate ProgressiVe RespIratory Decline in Idiopathic Pulmonary Fibrosis (MAVRIC-IPF)#297939
Record · ID 303701
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive